Literature DB >> 10805106

Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions.

J Takahashi1, T Fukuda, J Tanaka, M Minamitani, H Fujigasaki, T Uchihara.   

Abstract

Neuronal intranuclear hyaline inclusion disease (NIHID) is a group of neurodegenerative disorders characterized by the presence of intranuclear inclusions in neurons (NIs). We report here clinicopathological findings of a 25-year-old female patient who died after 13 years of a clinical course characterized by progressive gait disturbance and movement disorders. Histological examination revealed widespread NIs with neuronal loss in restricted regions; neuronal loss was severe in the subthalamic nucleus, internal pallidum, substantia nigra, Edinger-Westphal nucleus and Purkinje cell layer. Quantification of the NIs combined with a graded evaluation of neuronal loss revealed an overall tendency for more severe neuronal loss to be accompanied by a lower frequency of NIs. A morphological similarity to the nuclear inclusions recently identified in several CAG repeat diseases prompted us to examine the immunolocalization of ubiquitin and expanded polyglutamine stretches, which demonstrated the presence of ubiquitin at the periphery of most NIs. An expanded polyglutamine stretch was seen in the center of limited number of NIs. These findings indicate that abnormal fragments such as expanded polyglutamine regions are incorporated into the inclusion, aggregated in its center, and thereby metabolized by a ubiquitin-dependent proteolytic pathway. Although it remains to be elucidated how the formation of NIs is related to neuronal degeneration, our findings suggest that NIs are formed in the process of sequestering or degrading abnormal protein fragments and formation of NIs may not be immediately toxic to neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805106     DOI: 10.1007/s004010051166

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.

Authors:  Sabrina Mosaheb; Julian R Thorpe; Lida Hashemzadeh-Bonehi; Eileen H Bigio; Marla Gearing; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2005-07-16       Impact factor: 17.088

2.  Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease.

Authors:  Masataka Nakamura; Melissa E Murray; Wen-Lang Lin; Hirofumi Kusaka; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

3.  Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.

Authors:  U Nagaoka; T Uchihara; K Iwabuchi; H Konno; M Tobita; N Funata; S Yagishita; T Kato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

4.  Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

Authors:  Kathryn McFadden; Ronald L Hamilton; Sam J Insalaco; Lawrence Lavine; Majeed Al-Mateen; Guoji Wang; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

5.  Cognitive profiles in adult-onset neuronal intranuclear inclusion disease: a case series from the memory clinic.

Authors:  Fen Wang; Xiaowei Ma; Yuqing Shi; Longfei Jia; Xiumei Zuo; Yueyi Yu; Hongmei Jin; Yi Tang; Dongmei Guo; Jianping Jia
Journal:  Neurol Sci       Date:  2020-11-02       Impact factor: 3.307

6.  Visceral neuropathy and intestinal pseudo-obstruction in a murine model of a nuclear inclusion disease.

Authors:  Christine M Clarke; Cara Plata; Bonnie Cole; Karen Tsuchiya; Albert R La Spada; Raj P Kapur
Journal:  Gastroenterology       Date:  2007-08-21       Impact factor: 22.682

Review 7.  Decoding the role of coiled-coil motifs in human prion-like proteins.

Authors:  Molood Behbahanipour; Javier García-Pardo; Salvador Ventura
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

Review 8.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.